Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Janssen COVID-19 vaccine returns to Military Health System

Image of Military personnel wearing a face mask and a face shield administering the COVID-19 vaccine. Navy Hospitalman Jared Houchen, Combined Arms Training Center Camp Fuji Branch Health Annex, Gotenba, Shizuoka, Japan, administers the Janssen COVID-19 vaccine to a Marine at the installation March 16. CATC Camp Fuji, which sees a high number of transient training units, was the first installation in Japan to administer the single-dose vaccine (Photo by: Katie Gray, Marine Corps Installations Pacific).

Doses of the Janssen COVID-19 vaccine are now available to those in the Military Health System eligible and authorized to receive COVID-19 vaccinations, said Air Force Col. Jennifer Garrison, DOD COVID-19 Vaccine Program Operation Team Lead for the Department of Defense.

The Food and Drug Administration and the Centers for Disease Control and Prevention gave the greenlight to resuming use of the Janssen (also called Johnson & Johnson) vaccine April 23.

Aligning to the CDC, the MHS plan was subsequently approved by the White House and the CDC, Garrison said.

Defense Health Agency Director Army Lt. Gen. (Dr.) Ronald Place said: "We have full confidence that the J&J vaccine is safe and effective in preventing COVID-19 and that the data shows the vaccine's known potential benefits outweigh its known and potential risks."

The vaccine received FDA emergency use authorization Feb. 27 and was put on pause by the FDA and the CDC April 13 due to a small instance of those vaccinated with the Janssen product developing a rare, but serious blood clotting disorder that has now been named Thrombosis with Thrombocytopenia Syndrome (TTS).

TTS occurred at a rate of about 7 per 1 million vaccinated women between the ages of 18 and 49. For women 50 and older and men of all ages, this adverse event is even more rare.

FDA has added a warning to the Janssen COVID-19 vaccine emergency use authorization and fact sheets regarding the clotting events, CDC said. As of April 23, TTS had not been linked to the Pfizer-BioNTech or Moderna vaccines.

As of April 21, approximately 7.98 million doses of the Janssen COVID-19 vaccine had been administered in the United States, the CDC said in a report released April 27.

More than 2.62 million doses of the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines have been given to those eligible and authorized within the Military Health System (MHS), and more than 438,000 have been administered to MHS beneficiaries at retail pharmacies and other non-DOD sites, Place explained during a news conference April 21.

The Janssen vaccine makes up less than 3% of the doses provided to the Department of Defense, according to the DOD.

So far, Place said, there have been no cases reported in the military of the blood clotting serious adverse event, but data are being reviewed.

Out of an abundance of caution, CDC said it would review the Janssen data through its Advisory Committee on Immunization Practices (ACIP). The committee met April 14 and decided to keep the pause in vaccinations in place while it further reviewed the data from the Janssen large-scale clinical trials and the adverse events. On April 23, the ACIP recommended the restart of Janssen vaccinations.

A review of all available data shows that the one-shot Janssen COVID-19 vaccine's "known and potential benefits outweigh its known and potential risks for those recommended to receive it," the CDC announced April 25.

However, "women younger than 50 years old should be aware of the rare but increased risk of the TTS adverse event, and that there are other COVID-19 vaccine options available for which this risk has not been seen," CDC said.

People who have received the Janssen vaccine who develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider, the CDC said.

The pause allowed the CDC to re-emphasize with health care providers the importance of reporting severe events in people who have received this vaccine, as well as how to report such events. The pause also gave experts time to carefully review all available data and conduct a risk-benefit analysis of the vaccine.

Military vaccination sites have continued local planning and messaging for reintroduction of the Janssen vaccine. Any products or processes that need to be changed based on the CDC's April 27 "Morbidity and Mortality Weekly Report" and its clinicians' briefing will be finalized April 28, Garrison said. The DHA Director's directive to resume vaccinations with any additional guidance or changes required will be produced and published.

The Janssen vaccine is a replication-deficient adenovirus-vectored vaccine like the AstraZeneca/Oxford vaccine, which has not yet received FDA emergency use authorization.

This means it uses a different virus, such as measles or adenovirus, which is genetically engineered so that it can produce coronavirus proteins in the body and trigger the immune system to make antibodies against those proteins.

The viruses used in viral-vector vaccines are weakened or inactivated, so they cannot cause disease or harm humans. Viral-vector vaccines are also relatively fragile and must be maintained at temperatures that allow them to remain intact to work optimally.

The resource center on the Pfizer, Moderna and Janssen vaccines provides a plethora of information for MHS health care professionals.


You also may be interested in...

COVID-19 Booster Shots are Now Available – What You Need to Know

Containers of the Pfizer COVID-19 vaccine. Each vial contains six doses for vaccination against the COVID-19 virus.

Booster shots are now recommended for millions of people – but many others will have to wait for additional approvals.

Health Promotion duo optimizes health on Incirlik Air Base

Article Around MHS
Air Force Capt. Sydney Sloan, 39th Operational Medical Readiness Squadron health promotion element chief (right), and Air Force Senior Airman Gloriann Manapsal, 39th Operational Medical Readiness Squadron health promotion technician (left), promote making healthy choices at the Sultan’s Inn Dining Facility on Incirlik Air Base, Turkey.

The 39th Operation Medical Readiness Squadron health promotion team provides and integrates evidence-based programs to optimize the health and readiness, even during these unprecedented times.

Myths & facts about the vax - debunking common COVID-19 vaccine myths

Myths and facts about the vax

The COVID-19 vaccine has been mandated across the Department of Defense and despite its demonstrated effectiveness and safety, a host of myths have left some Airmen and Guardians hesitant to receive it. While social media posts and some news outlets may make it harder to keep up with what is fact or fiction, the science is clear … approved COVID-19 vaccines work.

Retired colonel leads Fort Irwin COVID response mission

Article Around MHS
Army Col. Richard Hopkins, the COVID-19 response coordinator with Weed Army Community Hospital, collects paperwork from a Soldier who received the COVID-19 vaccine at a vaccination event.

Retired Army Col. Richard Hopkins volunteered under the Army’s COVID-19 Retiree Recall Program to return to service as the COVID-19 response coordinator for Weed Army Community Hospital and Fort Irwin, California.

ARNORTH military support to FEMA begins in Tennessee, continues in five states

Article Around MHS
Prepared COVID-19 vaccine shots wait to be administered to an Airman. Members of the 134th Air Refueling Wing were eligible to receive their COVID-19 vaccines during Unit Training Assembly here May 2nd, 2021.

At the request of the Federal Emergency Management Agency, approximately 20 military medical personnel deployed to Tennessee to support civilian healthcare workers treating COVID-19 patients in local hospitals.

COVID-19 can lead to long-term health concerns

Article Around MHS
Debra Lamb, a 30-year civil service veteran at Ft. Carson, contracted the COVID-19 virus late in 2020 and experienced a harrowing ordeal before partially recovering months later.

Debra Lamb, a 30-year civil service veteran at Ft. Carson, contracted the COVID-19 virus late in 2020 and experienced a harrowing ordeal before partially recovering months later.

DODEA Schools Keeps On With In-Person Classes, and Fall Sports, Too

Kids playing football

DODEA schools are striving to continue in-person learning in the 2021-22 school year.

6th Medical Group Delivers Mandatory Vaccines

Article Around MHS
An Airman from the 6th Medical Group prepares a COVID-19 vaccine for distribution at MacDill Air Force Base, Florida.

Airmen from the 6th Medical Group began redistributing doses of the COVID-19 vaccine at MacDill Air Force Base, Florida, on Sept. 9, 2021. This comes after the Secretary of Defense issued a memorandum on Aug. 23, 2021, mandating all active duty personnel to be fully vaccinated against COVID-19.

After the ventilator COVID survivor advocates for vaccine

Article Around MHS
Tim Harris is sedated while on a ventilator

Tim Harris, a mobilization and planning specialist, U.S. Army Medical Center of Excellence, is sedated while on a ventilator at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, June 27, 2020.

Army Medicine Europe Provides Additional COVID Vaccinations for Immune Compromised

Article Around MHS
Franz Dietrich, a German local national assigned to Training Support Activity Europe, receives a COVID-19 vaccination at the 7th Army Training Command's (7ATC) Rose Barracks, Vilseck, Germany, May 4, 2021. The U.S. Army Health Clinics at Grafenwoehr and Vilseck conducted a "One Community" COVID-19 vaccine drive May 3-7 to provide thousands of appointments to the 7ATC community of Soldiers, spouses, Department of the Army civilians, veterans and local nationals employed by the U.S. Army. (U.S. Army photo by Markus Rauchenberger)

Army medical treatment facilities in Europe are now offering an additional dose of COVID vaccine for immune compromised beneficiaries.

The COVID-19 Pandemic: How Health Care Workers are Coping

a nurse helping a COVID-19 patient

For health care providers, experiencing the pandemic inside a hospital has brought

Increased COVID Restrictions on the Pentagon Reservation

Military personnel wearing a face mask

Due to the increase in COVID-19 cases and positive test cases in the National Capital Region, the Pentagon Reservation will move to Health Protection Condition Bravo Plus (Bravo+)

As Fitness Tests Resume, Troops Seek Post-COVID Exercise Routines

Military personnel physically training

Keeping fit during pandemic proves hard for some.

Digital health innovation emerges during COVID-19 pandemic

The Defense Health Agency’s Connected Health Branch was there to support, advise and deliver new health innovations throughout the pandemic. (Graphic courtesy of DHA Connected Health)

The DHA's Connected Health Branch was there to support, advise, and deliver new health innovations throughout the pandemic.

COVID-19 Booster Shots

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

Page 6 of 25 , showing items 76 - 90
First < ... 6 7 8 9 10  ... > Last 
Refine your search
Last Updated: May 04, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery